Compare GPMT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | TXMD |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 24.4M |
| IPO Year | 2017 | 2012 |
| Metric | GPMT | TXMD |
|---|---|---|
| Price | $1.19 | $2.06 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 183.7K | 17.4K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 12.99% | N/A |
| EPS Growth | 73.58 | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | $458.85 | N/A |
| Revenue Next Year | $8.63 | N/A |
| P/E Ratio | ★ N/A | $104.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $1.19 | $0.99 |
| 52 Week High | $3.12 | $2.95 |
| Indicator | GPMT | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 53.18 |
| Support Level | N/A | $2.07 |
| Resistance Level | $1.54 | $2.11 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.29 | 34.57 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.